Shares of the IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...
Shares of IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...
Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...
The agency announced Monday it was issuing draft guidance that will assist developers as they work through life cycle of ...
After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...
The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...
The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...
The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...
The FDA has issued draft guidance to provides recommendations to sponsors and other interested parties on the use of artificial intelligence to ...
The Food and Drug Administration issued draft guidance Jan. 6 on marketing submissions and lifecycle management for ...